C 4 Therapeutics Inc (CCCC)

Nov 26, 2025

Mineralys Therapeutics reports inducement award under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 26, 2025

Nov 26, 2025

Mineralys Therapeutics (Nasdaq: MLYS) grants 146K-share inducement option over 4 years - Stock Titan

Nov 26, 2025

Nov 26, 2025

Pipeline Momentum Drives C4 Therapeutics Despite Q3 EPS Miss - Seeking Alpha

Nov 26, 2025

Nov 25, 2025

CCCC SEC FilingsC4 Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Nov 25, 2025

Nov 25, 2025

C4 Therapeutics (NASDAQ: CCCC) fireside chat at Evercore conference Dec. 3 2025 - Stock Titan

Nov 25, 2025

Nov 25, 2025

C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference - MarketScreener

Nov 25, 2025

Nov 22, 2025

C4 Therapeutics files $400M mixed shelf offering - MSN

Nov 22, 2025

Nov 21, 2025

C4 Therapeutics Inc files for mixed shelf of up to $400 millionSEC filing - MarketScreener

Nov 21, 2025

Nov 21, 2025

[S-3] C4 Therapeutics, Inc. Shelf Registration Statement | CCCC SEC FilingForm S-3 - Stock Titan

Nov 21, 2025

Nov 20, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Nov 20, 2025

Nov 20, 2025

How C4 Therapeutics Inc. stock responds to policy changes2025 Support & Resistance & Growth Focused Investment Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Using economic indicators to assess C4 Therapeutics Inc. potentialWall Street Watch & Accurate Entry/Exit Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

C4 Therapeutics Inc. stock trend forecastJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com

Nov 19, 2025

Nov 18, 2025

Stoke Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 18, 2025

Nov 18, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Yahoo Finance

Nov 18, 2025

Nov 17, 2025

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 17, 2025

Nov 17, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Nov 17, 2025

Nov 16, 2025

C4 Therapeutics Inc. (CCCC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 16, 2025

Nov 16, 2025

Using data models to predict C4 Therapeutics Inc. stock movement2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - newser.com

Nov 16, 2025

Nov 16, 2025

What data driven models say about C4 Therapeutics Inc.’s futureMarket Performance Summary & Fast Moving Stock Watchlists - newser.com

Nov 16, 2025

Nov 16, 2025

Why hedge funds are buying C4 Therapeutics Inc. stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com

Nov 16, 2025

Nov 15, 2025

Volatility clustering patterns for C4 Therapeutics Inc.Trade Entry Summary & Safe Capital Allocation Plans - newser.com

Nov 15, 2025

Nov 15, 2025

Live market analysis of C4 Therapeutics Inc.July 2025 Recap & Capital Efficient Trade Techniques - newser.com

Nov 15, 2025

Nov 15, 2025

Is C4 Therapeutics Inc. stock positioned for digital transformationJuly 2025 WrapUp & Low Volatility Stock Suggestions - newser.com

Nov 15, 2025

Nov 14, 2025

Camp4 Therapeutics announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 14, 2025

Nov 14, 2025

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 14, 2025

Nov 14, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 14, 2025

Nov 14, 2025

How C4 Therapeutics Inc. stock benefits from strong dollarJuly 2025 Retail & Real-Time Volume Analysis Alerts - Fundação Cultural do Pará

Nov 14, 2025

Nov 12, 2025

Will earnings trigger a reversal in C4 Therapeutics Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com

Nov 12, 2025

Nov 12, 2025

Can trapped investors hope for a rebound in C4 Therapeutics Inc.2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com

Nov 12, 2025

Nov 12, 2025

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 12, 2025

Nov 11, 2025

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Nov 11, 2025

Nov 10, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail

Nov 10, 2025

Nov 10, 2025

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 10, 2025

Nov 07, 2025

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com

Nov 07, 2025

Nov 07, 2025

Fulcrum Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 07, 2025

Nov 07, 2025

Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Nov 07, 2025

Nov 07, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 07, 2025

Nov 07, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Nov 07, 2025

Nov 07, 2025

C4 Therapeutics Raises Cash And Wins Wall Street’s Favor - Finimize

Nov 07, 2025

Nov 07, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Nov 07, 2025

Nov 07, 2025

Vera Therapeutics (Nasdaq: VERA) inducement grants: 79,050 options and 39,915 RSUs - Stock Titan

Nov 07, 2025

Nov 06, 2025

C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com

Nov 06, 2025

Nov 06, 2025

C4 Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 06, 2025